Escape mutant analysis can identify antiviral drug binding sites and mechanisms of resistance in human rhinovirus 14.
No takes yet. Share an insight, caveat, or question.
May guide rhinovirus antiviral design; leaves open translation from animal escape-mutant mapping to clinical use.
Heinz et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: